Strength Profile of Hip Joint in Females With Primary Dysmenorrhea During Menstrual Cycle
NCT ID: NCT06615037
Last Updated: 2025-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2024-10-01
2025-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation Between Spinopelvic Alignment and Uterine Dimensions in Primary Dysmenorrhea
NCT06466954
Impact of Kinesiotaping Application on Pelvic Girdle Pain in Pregnant Women
NCT07292701
Effect of Kinesiotaping on Postpartum Pelvic Girdle Pain
NCT06705933
Effect of Shockwave Therapy on Low Back Pain in Primary Dysmenorrhea
NCT06762106
Prevalence and Impact on Quality of Life, Academic Performance, and Blood Indices of Heavy Menstrual Bleeding Among Female Students in Assiut University, Egypt
NCT07188259
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These trial participants; will be divided into two groups:
(Group A): Female with symptomatic PD according to WaLLID scale. (Group B): Female with asymptomatic PD according to WaLLID scale.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: Symptomatic dysmenorrhea
According to WaLLID Scale Questionnaire
Assess Hip joint strength by Biodex isokinetic dynamometer (System 4 Pro)
Assessment of the strength of hip flexors and extensors muscles:
* Participants will be in a supine-lying position, the highest reliability (ICC = 0.90) according to the results of the meta-analysis (Contreras et al., 2021).
* Seat orientation 0°.
* Dynamometer tilt 0° and orientation 0°.
* The axis of the dynamometer on the greater trochanter of the femur.
* The test parameters included a 0-90 degree range of motion.
* During the isokinetic testing movement, the hip was first flexed from a neutral (starting) position to 90° (for hip flexion) and then the direction of the movement was reversed (for hip extension)
* Angular speed at 120°/s which shows excellent reliability (ICC = 95%) with concentric contraction mode (Contreras et al., 2021) .
Group B: Asymptomatic dysmenorrhea
According to WaLLID Scale Questionnaire
Assess Hip joint strength by Biodex isokinetic dynamometer (System 4 Pro)
Assessment of the strength of hip flexors and extensors muscles:
* Participants will be in a supine-lying position, the highest reliability (ICC = 0.90) according to the results of the meta-analysis (Contreras et al., 2021).
* Seat orientation 0°.
* Dynamometer tilt 0° and orientation 0°.
* The axis of the dynamometer on the greater trochanter of the femur.
* The test parameters included a 0-90 degree range of motion.
* During the isokinetic testing movement, the hip was first flexed from a neutral (starting) position to 90° (for hip flexion) and then the direction of the movement was reversed (for hip extension)
* Angular speed at 120°/s which shows excellent reliability (ICC = 95%) with concentric contraction mode (Contreras et al., 2021) .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assess Hip joint strength by Biodex isokinetic dynamometer (System 4 Pro)
Assessment of the strength of hip flexors and extensors muscles:
* Participants will be in a supine-lying position, the highest reliability (ICC = 0.90) according to the results of the meta-analysis (Contreras et al., 2021).
* Seat orientation 0°.
* Dynamometer tilt 0° and orientation 0°.
* The axis of the dynamometer on the greater trochanter of the femur.
* The test parameters included a 0-90 degree range of motion.
* During the isokinetic testing movement, the hip was first flexed from a neutral (starting) position to 90° (for hip flexion) and then the direction of the movement was reversed (for hip extension)
* Angular speed at 120°/s which shows excellent reliability (ICC = 95%) with concentric contraction mode (Contreras et al., 2021) .
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ranges from 20 to 25 kg/m2.
* Having a regular menstrual cycle (28 ± 7 days with no intermittent bleeding).
* No pathology related to the pelvis.
* Having no injury in the lower limb.
* Not consuming contraceptives, dietary supplements and steroid drugs.
Exclusion Criteria
* Pregnancy or suspicion of pregnancy.
* Having given birth.
* Using an intrauterine device.
* Oral contraceptives or antidepressant use.
* Having a diagnosis of secondary dysmenorrhea.
* Surgical history involving the abdominal region, pelvic region, and/or the spine in the last year.
* Having musculoskeletal problems related to lower extremities.
* Having any psychiatric or gynecological problems.
* Suffering from premenstrual syndrome.
20 Years
25 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nourhan Mohamed Mitwally Amer
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nourhan Mohamed Mitwally Amer
Role: PRINCIPAL_INVESTIGATOR
Bachelor Physical Therapy- MUST
Amal Mohamed Yousef, Professor
Role: STUDY_CHAIR
Cairo University
Mai Mohamed Ali, Lecturer
Role: STUDY_DIRECTOR
Cairo University
Ehab Kamal Mohamed Younis, lecturer
Role: STUDY_DIRECTOR
Lecturer of obstetrics and gynecology - Faculty of Medicine - Misr university for science and technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC\012\005318
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.